Suppression of acute rejection in allogeneic rat lung transplantation: a study of the efficacy and pharmacokinetics of rapamycin derivative (SDZ RAD) used alone and in combination with a microemulsion formulation of cyclosporine

This publication has 20 references indexed in Scilit:

• SDZ RAD, A NEW RAPAMYCIN DERIVATIVE
  Transplantation, 1997
• Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide
  Current Opinion in Immunology, 1996
• TOR Mutations Confer Rapamycin Resistance by Preventing Interaction with FKBP12-Rapamycin
  Journal of Biological Chemistry, 1995
• RAPAMYCIN, A POTENT IMMUNOSUPPRESSIVE DRUG, CAUSES PROGRAMMED CELL DEATH IN B LYMPHOMA CELLS
  Transplantation, 1995
• Obliterative bronchiolitis after lung and heart-lung transplantation
  The Journal of Thoracic and Cardiovascular Surgery, 1995
• Anti-CD28 antibody- and IL-4-induced human T cell proliferation is sensitive to rapamycin
  Clinical and Experimental Immunology, 1993
• Management of Lung Transplant Rejection
  Chest, 1993
• Rapamycin inhibits IL-1-mediated interferon-gamma production in the YAC-1 T cell lymphoma
  Cytokine, 1993
• Rapamycin inhibits the phosphorylation of p70 S6 kinase in IL-2 and mitogen-activated human T cells
  Biochemical and Biophysical Research Communications, 1992
• Rapamycins: Antifungal, antitumor, antiproliferative, and immunosuppressive macrolides
  Transplantation Reviews, 1992